Biomarkers for predicting response to tyrosine kinase inhibitors in drug-sensitive and drug-resistant human bladder cancer cells

By  

Oncology Reports, Vol. 33, Iss. 2, 2015-01 ,pp. : 951-957

Spandidos Publications

Access to resources Recommend Favorite

Novel Oncogenic Protein Kinase Inhibitors for Cancer Therapy

By  

Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 4, Iss. 5, 2004-09 ,pp. : 449-455

Bentham Science Publishers

Access to resources Recommend Favorite

Protein Kinase C α is a marker for antiestrogen resistance and is involved in the growth of tamoxifen resistant human breast cancer cells

By Frankel Lisa   Lykkesfeldt Anne   Hansen Jens   Stenvang Jan  

Breast Cancer Research and Treatment, Vol. 104, Iss. 2, 2007-08 ,pp. : 165-179

Springer Publishing Company

Access to resources Recommend Favorite

Alteration of gene expression and DNA methylation in drug-resistant gastric cancer

By                    

Oncology Reports, Vol. 31, Iss. 4, 2014-01 ,pp. : 1883-1890

Spandidos Publications

Access to resources Recommend Favorite

Comparison of action of the anti-neoplastic drug lonidamine on drug-sensitive and drug-resistant human breast cancer cells: ^{31}P and ^{13}C nuclear magnetic resonance studies

By Vivi A.  

Breast Cancer Research and Treatment, Vol. 43, Iss. 1, 1997-03 ,pp. : 15-25

Springer Publishing Company

Access to resources Recommend Favorite